Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPRENORPHINE\NALOXONE vs BUPROPION: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BUPRENORPHINE\NALOXONE vs BUPROPION: Safety Overview

Metric BUPRENORPHINE\NALOXONE BUPROPION
Total FAERS Reports 21,631 35,634
Deaths Reported 1,119 8,577
Death Rate 5.2% 24.1%
Hospitalizations 2,872 10,246
Average Patient Age 40.3 yrs 44.6 yrs
% Female Patients 49.1% 70.7%
FDA Approval Date N/A Apr 12, 2017
Manufacturer N/A NuCare Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Discontinued